FEG
AGN

Financial Enhancement Group’s Allergan plc AGN Stock Holding History

Financial Enhancement Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-150
Closed -$22K – 336
2019
Q1 		$22K Sell
150
-2,155
-93% -$312K 0.01% 175
2018
Q4 		$439K Hold
2,305
– – 0.14% 66
2018
Q3 		$439K Buy
2,305
+573
+33% +$105K 0.14% 66
2018
Q2 		$289K Buy
1,732
+1,704
+6,086% +$274K 0.1% 67
2018
Q1 		$5K Buy
+28
New +$4.7K ﹤0.01% 215

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Financial Enhancement Group's AGN Position: Q2 2019 in Review

Financial Enhancement Group sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 150 shares — an estimated $22K sold.

Financial Enhancement Group first reported a position in AGN in Q1 2018 and held it in 5 quarters. The position peaked at $439K in Q4 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Financial Enhancement Group reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Financial Enhancement Group sold 150 Allergan plc shares in Q2 2019, an estimated $22K.
  • Financial Enhancement Group first reported a position in Allergan plc in Q1 2018 and held it in 5 quarters.
  • Financial Enhancement Group's Allergan plc position peaked at $439K in Q4 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Financial Enhancement Group's 13F filing for Q2 2019, filed 6 Aug 2019.